SGMO Share Price

Open 12.60 Change Price %
High 12.85 1 Day -0.20 -1.59
Low 12.40 1 Week 0.00 0.00
Close 12.40 1 Month -2.55 -17.06
Volume 861335 1 Year 7.95 178.65
52 Week High 17.06
52 Week Low 2.65
SGMO Important Levels
Resistance 2 12.82
Resistance 1 12.65
Pivot 12.55
Support 1 12.15
Support 2 11.98
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
MU 44.31 6.39%
MU 44.31 6.39%
MU 44.31 6.39%
RIMM 13.03 0.39%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
SCHS 0.04 33.33%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
HLIT 3.70 25.42%
OTT 2.39 25.13%
QNST 8.90 20.76%
VRTA 4.00 19.40%
SNSS 2.56 19.07%
GCFB 0.44 18.92%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
GMETP 0.15 -76.92%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

Sangamo BioSciences, Inc. (NASDAQ: SGMO)

SGMO Technical Analysis 1.5
As on 31st Oct 2017 SGMO Share Price closed @ 12.40 and we RECOMMEND Buy for LONG-TERM with Stoploss of 7.48 & Sell for SHORT-TERM with Stoploss of 13.50 we also expect STOCK to react on Following IMPORTANT LEVELS.
SGMO Target for December
1st Target up-side 15.54
2nd Target up-side 17.74
3rd Target up-side 19.94
1st Target down-side 9.26
2nd Target down-side 7.06
3rd Target down-side 4.86
Sangamo BioSciences, Inc. ( NASDAQ USA Symbol : SGMO )
Sector : Health Care Biotechnology: Biological Products (No Diagnostic Substances) And Other Stocks in Same Sector
BPAX
1.09 0.01 (0.93 %)
LT : Strong Sell
ST : Sell
LIFE
4.80 -0.10 (-2.04 %)
LT : Buy
ST : Buy
NABI
1.80 0.01 (0.56 %)
LT : Buy
ST : Strong Buy
ONXX
124.70 0.00 (0.00 %)
LT : Strong Buy
ST : Sell
SGMO
12.40 -0.20 (-1.59 %)
LT : Buy
ST : Sell
SGMO Other Details
Segment EQ
Market Capital 280839360.00
Sector Health Care Biotechnology: Biological Products (No Diagnostic Substances)
Industry
Offical website
SGMO Address
SGMO
N/A
SGMO Latest News
Interactive Technical Analysis Chart Sangamo BioSciences, Inc. ( SGMO NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Sangamo BioSciences, Inc.
SGMO Business Profile
Sangamo BioSciences, Inc. is a clinical stage biopharmaceutical company. The Company is engaged in the research, development and commercialization of zinc finger deoxyribonucleic acid (DNA)-binding proteins (ZFPs), a naturally occurring class of proteins. ZFPs can be engineered to make ZFP nucleases (ZFNs), proteins that can be used to modify DNA sequences in a variety of ways and ZFP transcription factors (ZFP TFs), proteins that can be used to turn genes on or off. The main focus for its Company is the development of human therapeutics and it is building a pipeline of ZFP Therapeutics. Its lead ZFP Therapeutic, SB-728-T, a ZFN-modified autologous T-cell product for the treatment of human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS), is the first therapeutic application of its ZFN technology and is being evaluated in an ongoing Phase 11 and two Phase I/II clinical trials. In October 2013, Sangamo BioSciences Inc acquired Ceregene Inc.